CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1 Hypertension PDF) Using large language models to assess public perceptions around glucagon like peptide 1 receptor agonists on social media Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine Semaglutide, a glucagon like peptide 1 (GLP 1) receptor agonist, has well established weight loss benefits. Cagrilintide, a long acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit